Amcor plcNYSE: AMCR

On June 15, 2026, Amcor announced two senior leadership appointments: Ryan Yost as Division President, Global Flexible Packaging Solutions, and Kate Pearlman as SVP, Investor Relations & Treasury; Yost brings 25 years of leadership at Avery Dennison, where he ran the ~$6B Materials Group. Shares rose about 1.7% on the news. The moves come as Amcor works through integration of its $10.4B Berry Global acquisition, targeting ~12% adjusted EPS growth in FY2026 and $650M in cost synergies by FY2028. The bear case: Amcor has lowered FY2026 adjusted earnings and free cash flow guidance on elevated inventories and Middle East supply-chain uncertainty, and integration costs remain a drag. Consensus rating is Moderate Buy.

Amcor appoints Yost, Pearlman to senior rolesstocktitan.netAmcor plc (AMCR) Latest Stock News & Headlinesfinance.yahoo.com

On June 15, 2026, Amcor announced key leadership appointments: Ryan Yost joins as Division President, Global Flexible Packaging Solutions, bringing 25 years at Avery Dennison where he most recently led the global $6 billion Materials Group. Kate Pearlman, a former Lowe's executive, was named SVP Investor Relations & Treasury, succeeding Tracey Whitehead, who remains an advisor through December 31, 2026. The moves come as Amcor works to integrate its $10.4 billion Berry Global acquisition and targets ~12% adjusted EPS growth for fiscal 2026 plus $650 million in cost synergies by fiscal 2028. The reshuffle aims to sharpen execution in flexibles and investor communications. The bear case: Amcor recently lowered fiscal 2026 adjusted earnings and free cash flow guidance on elevated inventories and Middle East supply chain uncertainty, so leadership change adds execution risk during a complex integration.

Amcor appoints Yost, Pearlman to senior rolesstocktitan.netAmcor Announces Key Leadership Changes in Global Operationstipranks.comAmcor plc (AMCR) Latest Press Releasesfinance.yahoo.com

No material news in the last 48 hours.

No material news in the last 48 hours.

Amcor reported Q3 FY2026 results on May 6 with adjusted EPS of $0.96 (up 6% YoY) and revenue of $5.91B beating $5.71B consensus. Berry Global integration synergies of $77M hit the high end of guidance, and full-year synergy target was raised to $270M from $260M. However, the company cut FY26 free cash flow guidance to $1.5B-$1.6B from $1.8B-$1.9B. In response, Citi cut PT to $47 from $54 (keeps Buy), JPMorgan cut to $44 from $50 (keeps Overweight), and Morgan Stanley also cut its PT. Board declared $0.65 dividend (ex-date May 28), up from $0.6375. Amcor also announced consolidation of corporate functions to a new Miami HQ starting 2027.

Amcor Q3 FY2026 slides: synergies exceed targets, guidance revisedinvesting.comAmcor plc stock: Q3 FY2026 results beat on synergies, guidance raisedad-hoc-news.deAmcor plc stock: Morgan Stanley cuts price target on lower earningsad-hoc-news.de

Amcor reported fiscal Q3 2026 results on May 6, 2026, with adjusted EPS of $0.96 (up 6% YoY) and revenue of $5.91B exceeding forecasts by $200M; shares surged 8.26% in premarket to $40.75. Third-quarter synergies of $77M landed at the upper end of guidance, with full-year synergy expectations raised to $270M from $260M. The Board declared a $0.65 quarterly dividend (up from $0.6375). On May 11, Amcor's Asia Pacific Innovation Center received CNAS accreditation, accepting test data in 116 countries. Bear case: FY26 free cash flow guidance cut to $1.5B-$1.6B from $1.8B-$1.9B due to higher inventory at higher cost amid the Middle East conflict, and Citi and JPMorgan both lowered price targets (Citi $47 from $54, JPMorgan $44 from $50).

Amcor Reports Solid Q3 Resultsprnewswire.comAmcor Q3 FY2026 slides synergiesinvesting.comAmcor CNAS accreditation Chinastocktitan.net

No material news in the last 48 hours. Earlier in May, Amcor reported Q3 FY2026 adjusted EPS of $0.96 (+6% YoY) and revenue of $5.91B beating by ~$200M, lifted FY26 synergy expectations to $270M from $260M post Berry merger, but cut FY26 free cash flow guidance to $1.5B-$1.6B from $1.8B-$1.9B. Citi lowered its PT to $47 from $54 (Buy) and JPMorgan cut to $44 from $50 (Overweight), while Morgan Stanley also trimmed its target. Quarterly dividend raised to 65.0 cents from 63.75 cents.

Amcor Q3 FY2026 results beat on synergies, guidance raisedad-hoc-news.deAmcor Q3 FY2026 slides: synergies exceed targets, guidance revisedinvesting.comMorgan Stanley cuts Amcor price target on lower earningsad-hoc-news.de

Amcor released Q3 FY2026 results on May 6, 2026, with reported EPS of $0.96 matching expectations and net sales of $5.91B up 77% YoY driven by the Berry Global acquisition, beating the $5.71B estimate. Q3 synergies of $77M came in at the upper end of the $70-80M guidance range, and management raised full-year fiscal 2026 synergy expectations to $270M from the original $260M target. However, the company cut its FY26 free cash flow outlook to $1.5B-$1.6B from $1.8B-$1.9B. Morgan Stanley reduced its price target citing lower earnings; Citi maintained Buy at $47 PT, while JPMorgan kept Overweight but lowered PT to $44 from $50. The company also announced a $0.65 dividend with May 28 ex-date.

Amcor Q3 FY2026 Results Beat on Synergiesad-hoc-news.deAmcor Q3 FY2026 Slides: Synergies Exceed Targetsinvesting.comMorgan Stanley Cuts Amcor Price Targetad-hoc-news.de

Amcor announced May 11 that its Asia Pacific Innovation Center received CNAS accreditation in China, allowing test data accepted in 116 countries to speed packaging compliance. Q3 FY26 results reported May 6 showed $5.91B revenue (+77% on Berry acquisition) and adjusted EPS of $0.96, with Q3 synergies of $77M at upper end of $70-80M guidance; YTD synergies hit $170M and management raised full-year synergy expectations to $270M from $260M. Dividend hiked to $0.65/share. However, FY26 free cash flow guidance cut to $1.5-1.6B from $1.8-1.9B, and EPS guidance was also lowered. Citi cut PT to $47 from $54, JPMorgan to $44 from $50. Corporate HQ moving to Miami in 2027.

Amcor Q3 FY2026 Resultsinvesting.comAmcor CNAS Accreditation in Chinastocktitan.netAmcor Analyst Price Targetsmarketbeat.com

Citi maintained its Buy rating on Amcor PLC on May 10, 2026 as shares trade near 52-week lows around $37.95-$40.39. Amcor reported adjusted EPS of $2.79 for the first nine months of fiscal 2026, 11% higher than prior year including Berry contributions. However, management downgraded full-year guidance, now expecting fiscal 2026 EPS about 2% lower at the midpoint and less free cash flow. The company opened a healthcare packaging coating facility in Subang Jaya representing a $35 million investment. Deutsche Bank flagged the U.S. packaging sector faces a challenging macroeconomic backdrop in 2026. The stock currently yields 6.6% dividend on a 27.03 P/E.

Amcor plc Investor Newsamcor.comAMCR Stock Price - Yahoo Financefinance.yahoo.comAMCR Stock Analysis - Seeking Alphaseekingalpha.com

Amcor reported Q3 FY2026 results on May 6, 2026 — its first full year post-Berry Global merger — with net sales surging to $5.914B (vs $3.333B prior year, beating $5.73B consensus by $178M) and net income of $278M. EPS of $0.96 matched expectations. Q3 synergies hit $77M (upper end of $70-80M guidance), bringing year-to-date synergies to $170M, and the company raised full-year FY26 synergy guidance to $270M (vs the original $260M target). Amcor declared a higher quarterly dividend of $0.60 and announced CNAS accreditation of its Asia Pacific Innovation Center lab in China on May 11. Beginning 2027, the company will consolidate select corporate functions in Miami, FL. Risk: despite operational beats, Citi cut its price target to $47 from $54 on May 8 and JPMorgan cut to $44 from $50 (Overweight maintained), citing macro and FX headwinds.

Amcor Q3 FY2026 slides: synergies exceed targets, guidance revisedinvesting.comAmcor grows profit and scale after Berry mergerstocktitan.netAmcor plc stock: Achieves CNAS lab accreditation in Chinaad-hoc-news.de

On May 11, 2026, Amcor announced its Asia Pacific Innovation Center laboratory received accreditation from the China National Accreditation Service for Conformity Assessment (CNAS), a quality-credentialing milestone supporting its expanded post-Berry-merger R&D footprint. This follows Q3 FY2026 results last week showing net sales of $5,914M (vs. $3,333M YoY) but EPS of $0.96 missing the $0.99 consensus. JPMorgan lowered its price target to $44 from $50 (Overweight maintained). Bear case: the CNAS news is marginal, and the recent JPM target cut plus EPS miss suggest synergy-driven optimism may already be priced in.

Amcor plc achieves CNAS lab accreditation in Chinaad-hoc-news.de

Amcor reported Q3 FY26 on May 6 with net sales of $5.9B (up ~77% YoY post-Berry merger), beating revenue estimates of $5.80B, while EPS of $0.96 missed the $0.99 consensus. The company raised its quarterly dividend to $0.65 per share but cut FY26 adjusted EPS guidance to $3.98-$4.03 from prior $4.00-$4.15. Synergy capture from the Berry merger of $77M landed at the high end of guidance, bringing year-to-date synergies to $170M with full-year target raised to $270M. JPMorgan lowered its price target to $44 from $50 while maintaining Overweight. Amcor will move select corporate functions to a new Miami HQ in 2027. Risk: free cash flow concerns and inventory levels weigh on outlook.

Amcor Q3 FY2026 Slides - Investing.cominvesting.comAmcor Q3 Earnings - Stocktitanstocktitan.netAmcor PLC Stock - ad-hoc-newsad-hoc-news.de